Klencke Barbara bought ALXO
September 17, 2025 · Form 4 insider transaction
Klencke Barbara bought 300,000 shares of ALX Oncology Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
300,000
Price
$0.00
Total value
N/A
InsiderKlencke Barbara
RoleOfficer, Director
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateSeptember 17, 2025
Filing dateSeptember 19, 2025
Shares owned after300,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third of the shares subject to the option vest on each of September 17, 2025, January 31, 2026 and June 30, 2026.